Skip to main content
Equibles

Hikari Power Ltd

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1606152 TOKYO, M0
Back to CRVS Full portfolio

Position in CRVS

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$730,900
+$346,216 QoQ
Shares Held
49,959
0.0% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Hikari Power Ltd holds $1,171,468 across 4 Biotechnology names. CRVS ranks #1 (62.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CRVS
Corvus Pharmaceuticals, Inc.
This page 		49,959 $730,900
2 AVXL
Anavex Life Sciences Corp.
 85,585 $262,745
3 OCUL
Ocular Therapeutix, Inc
 17,000 $143,990
4 ALDX
Aldeyra Therapeutics, Inc.
 20,020 $33,833

All Filings in CRVS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $730,900 49,959
2025-12-31 $384,684 49,959
2025-09-30 $368,197 49,959
2025-06-30 $199,836 49,959
2025-03-31 $158,869 49,959
2024-12-31 $267,280 49,959
2024-09-30 $263,783 49,959
2024-06-30 $90,925 49,959
2024-03-31 $88,927 49,959
2023-12-31 $87,927 49,959
2023-09-30 $72,940 49,959
2023-06-30 $114,406 49,959
2023-03-31 $45,462 49,959
2022-12-31 $42,465 49,959
2022-09-30 $40,916 49,959
2022-06-30 $49,459 49,959
2022-03-31 $81,932 49,959
2021-12-31 $48,101 19,959
2021-09-30 $96,601 19,959
2021-06-30 $53,290 19,959
2021-03-31 $61,473 19,959
2020-12-31 $71,054 19,959
2020-09-30 $80,035 19,959
2020-06-30 $165,808 60,959
2020-03-31 $128,623 60,959

Report a Problem

Category
Description
Email (optional, for follow-up)